Evaluating the Use of Large-dose, Extended Interval Vancomycin Intravenous Administration for Skin and Soft Tissue Infections — VOD

Skin and Soft Tissue Infections Clinical Trial

Official title:
Evaluating the Use of Large-dose, Extended Interval Vancomycin Intravenous Administration for Skin and Soft Tissue Infections

Status Completed

Clinical Trial Summary

Our hypothesis is that large-dose, extended-interval vancomycin (30 mg/kg IV q24h) administration provides non-inferior clinical efficacy and microbiological efficacy to standard vancomycin (15 mg/kg IV q12h) administration for skin and soft tissue infections in an outpatient setting.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01037192
Study type	Interventional
Source	Fraser Health
Contact
Status	Completed
Phase	N/A
Start date	March 2010
Completion date	September 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03744741` - HostDx Sepsis in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections: a Multicenter Pilot Study
Terminated	`NCT01076049` - The Effect of Irrisept for Irrigation of Skin and Soft Tissue Infections (Irrisept USF Study)	N/A
Recruiting	`NCT03941509` - Nurse-led Antimicrobial Stewardship Intervention to Increase Antibiotic Appropriateness in Residential Aged Care Facilities	N/A
Completed	`NCT05270135` - ASAP: Access to Syringes at Pharmacies for the Prevention of Bloodborne Infections Among People Who Inject Drugs	N/A
Completed	`NCT00989872` - Safety and Pharmacokinetics of Ascending Single Oral Doses of EDP-322 in Nonfasting and Fasting Healthy Volunteers	Phase 1